Alexandre Gapihan’s practice is primarily focused on matters relating to the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and the pharmaceutical industry, including the approval, regulation, promotion, and sale of drugs, medical devices, and dietary supplements. Alexandre excels in assisting clients in navigating the complex legal and regulatory frameworks that impact their business.
Prior to joining Morgan Lewis, Alexandre was an associate at another international law firm. He is a native French speaker and is conversational in Mandarin Chinese.